The prognostic factors of systemic sclerosis for survival among Koreans

Clinical Rheumatology

Volumn 29, Issue 3, 2010, Pages 297-302

  Kim, Jinhyun ^a   Park, Sue Kyung ^a   Moon, Ki Won ^a   Lee, Eun Young ^a   Lee, Yun Jong ^a   Song, Yeong Wook ^a   Lee, Eun Bong ^a  

^a Seoul National University   (South Korea)

Author keywords

Korean; Prognostic factors; Survival; Systemic sclerosis

Indexed keywords

SCL 70 ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; GENDER; HEART DISEASE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RISK FACTOR; SURVIVAL RATE; SYSTEMIC SCLEROSIS; FIBROSIS; HEART MUSCLE; KIDNEY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SKIN; SOUTH KOREA;

ADULT; AGE OF ONSET; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RISK FACTORS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 77950623731     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1324-7     Document Type: Article

References (26)

1. SK Agarwal FK Tan FC Arnett 2008 Genetics and genomic studies in scleroderma (systemic sclerosis) Rheum Dis Clin North Am 34 17 40 10.1016/j.rdc.2007.10.001 18329530 (Pubitemid 351337628)
2. H Chifflot B Fautrel C Sordet E Chatelus J Sibilia 2008 Incidence and prevalence of systemic sclerosis: a systematic literature review Semin Arthritis Rheum 37 223 235 10.1016/j.semarthrit.2007.05.003 17692364
3. MD Mayes JV Lacey Jr J Beebe-Dimmer BW Gillespie B Cooper TJ Laing, et al. 2003 Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large us population Arthritis Rheum 48 2246 2255 10.1002/art.11073 12905479 (Pubitemid 36959206)
4. VD Steen TA Medsger 2007 Changes in causes of death in systemic sclerosis, 1972-2002 Ann Rheum Dis 66 940 944 10.1136/ard.2006.066068 17329309 (Pubitemid 46999798)
5. CP Simeon L Armadans V Fonollosa R Solans A Selva M Villar, et al. 2003 Mortality and prognostic factors in spanish patients with systemic sclerosis Rheumatol (Oxford) 42 71 75 10.1093/rheumatology/keg033 1:STN:280: DC%2BD3s%2FgtlOmtg%3D%3D (Pubitemid 36131570)
6. C Ferri G Valentini F Cozzi M Sebastiani C Michelassi G La Montagna, et al. 2002 Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients Medicine 81 139 153 10.1097/00005792- 200203000-00004 11889413 (Pubitemid 34218569)
7. FF Al-Dhaher JE Pope JM Ouimet 2008 Determinants of morbidity and mortality of systemic sclerosis in Canada Semin Arthritis Rheum 10.1016/j.semarthrit.2008.06.002 18706680
8. L Czirjak G Kumanovics C Varju Z Nagy A Pakozdi Z Szekanecz, et al. 2008 Survival and causes of death in 366 hungarian patients with systemic sclerosis Ann Rheum Dis 67 59 63 10.1136/ard.2006.066340 1:STN:280:DC%2BD2sjjslKntA%3D%3D 17519276
9. JP Ioannidis PG Vlachoyiannopoulos AB Haidich TA Medsger Jr M Lucas CJ Michet, et al. 2005 Mortality in systemic sclerosis: an international meta-analysis of individual patient data Am J Med 118 2 10 10.1016/j.amjmed. 2004.04.031 15639201 (Pubitemid 40082450)
10. S Jacobsen S Ullman GQ Shen A Wiik P Halberg 2001 Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis J Rheumatol 28 2454 2459 1:STN:280: DC%2BD3Mnmt1Oqtg%3D%3D 11708418 (Pubitemid 33031976)
11. E Hachulla P Carpentier V Gressin E Diot Y Allanore J Sibilia, et al. 2009 Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French itinerair-sclerodermie study Rheumatol (Oxford) 48 304 308 10.1093/rheumatology/ken488
12. S Jacobsen P Halberg S Ullman 1998 Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) Br J Rheumatol 37 750 755 10.1093/rheumatology/37.7.750 1:STN:280:DyaK1cznvVWmsQ%3D%3D 9714351 (Pubitemid 28370668)
13. CP Simeon L Armadans V Fonollosa M Vilardell J Candell C Tolosa, et al. 1997 Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis Ann Rheum Dis 56 723 728 10.1136/ard.56.12.723 1:STN:280:DyaK1c7lslagtA%3D%3D 9496151 (Pubitemid 28064838)
14. VD Steen TA Medsger Jr 2000 Severe organ involvement in systemic sclerosis with diffuse scleroderma Arthritis Rheum 43 2437 2444 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U 1:STN:280:DC%2BD3M%2FktFequw%3D%3D 11083266
15. K Nishioka I Katayama H Kondo H Shinkai H Ueki K Tamaki, et al. 1996 Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan J Dermatol 23 677 682 1:STN:280:DyaK2s7ivVCntw%3D%3D 8973032
16. S Ruangjutipopan N Kasitanon W Louthrenoo W Sukitawut R Wichainun 2002 Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis J Med Assoc Thai 85 1204 1209 12546318 (Pubitemid 36255032)
17. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee 1980 Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 581 590 10.1002/art.1780230510 (Pubitemid 10101764)
18. EC LeRoy C Black R Fleischmajer S Jablonska T Krieg TA Medsger, et al. 1988 Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 202 205 1:STN:280:DyaL1c3gtVWnsg%3D%3D 3361530 (Pubitemid 18073738)
19. NS Goh SR Desai S Veeraraghavan DM Hansell SJ Copley TM Maher, et al. 2008 Interstitial lung disease in systemic sclerosis: a simple staging system Am J Respir Crit Care Med 177 1248 1254 10.1164/rccm.200706-877OC 18369202 (Pubitemid 351860934)
20. M Peters-Golden RA Wise P Schneider M Hochberg MB Stevens F Wigley 1984 Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis Medicine 63 221 231 10.1097/00005792-198407000-00004 1:STN:280:DyaL2c3ksFWisw%3D%3D 6738343 (Pubitemid 14090668)
21. DP Tashkin PJ Clements RS Wright H Gong Jr MS Simmons PA Lachenbruch, et al. 1994 Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis Chest 105 489 495 10.1378/chest.105.2.489 1:STN:280:DyaK2c7jvFCjuw%3D%3D 8306752 (Pubitemid 24066723)
22. SK Park TH Kim JB Jun SS Jung SC Bae TY Kim, et al. 2001 The clinical features and autoantibody profile of progressive systemic sclerosis in Korea J Korean Rheum Assoc 8 243 252
23. EB Lee CW Han HJ Baek SW Kang HS Cha HA Kim, et al. 1999 Study on the clinical characteristics of systemic sclerosis Korean J Med 57 1053 1061
24. EB Lee JY Kim YJ Lee A Abdallah P Lympany YW Song 2004 Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis Tissue antigens 63 491 495 10.1111/j.1399-0039.2004.00185.x 1:CAS:528: DC%2BD2cXkvFGrur8%3D 15104684 (Pubitemid 38648218)
25. EC LeRoy TA Medsger Jr 2001 Criteria for the classification of early systemic sclerosis J Rheumatol 28 1573 1576 1:STN:280:DC%2BD38%2Fit1Oqsw%3D%3D 11469464 (Pubitemid 32660630)
26. EJ Cepeda JD Reveille 2004 Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance Curr Opin Rheumatol 16 723 732 10.1097/01.bor.0000144760.37777.fa 1:CAS:528:DC%2BD2cXhtVaht7jN 15577611 (Pubitemid 39425546)